Cell Source, Inc. announced a private placement of 8% convertible notes for gross proceeds of $4,760,170 on March 22, 2024. The notes are convertible into series C convertible preferred stock at a conversion price of $7.50 per share. The company also issued investors warrants to purchase 4,321,926 shares at an exercise price of $1.25 per share.